These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17273875)

  • 1. Acute effects of naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice.
    Kamdar NK; Miller SA; Syed YM; Bhayana R; Gupta T; Rhodes JS
    Psychopharmacology (Berl); 2007 Jun; 192(2):207-17. PubMed ID: 17273875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel mu-opioid antagonist, GSK1521498, reduces ethanol consumption in C57BL/6J mice.
    Ripley TL; Sanchez-Roige S; Bullmore ET; Mugnaini M; Maltby K; Miller SR; Wille DR; Nathan P; Stephens DN
    Psychopharmacology (Berl); 2015 Sep; 232(18):3431-41. PubMed ID: 26141191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol drinking-in-the-dark facilitates behavioral sensitization to ethanol in C57BL/6J, BALB/cByJ, but not in mu-opioid receptor deficient CXBK mice.
    Tarragón E; Baliño P; Aragon CM; Pastor R
    Pharmacol Biochem Behav; 2012 Mar; 101(1):14-23. PubMed ID: 22138236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.
    Hwa LS; Shimamoto A; Kayyali T; Norman KJ; Valentino RJ; DeBold JF; Miczek KA
    Addict Biol; 2016 Jan; 21(1):111-24. PubMed ID: 25262980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice.
    Rhodes JS; Best K; Belknap JK; Finn DA; Crabbe JC
    Physiol Behav; 2005 Jan; 84(1):53-63. PubMed ID: 15642607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.
    Navarro M; Luhn KL; Kampov-Polevoy AB; Garbutt JC; Thiele TE
    Alcohol Clin Exp Res; 2019 May; 43(5):783-790. PubMed ID: 30817015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonin 2C receptor agonist lorcaserin, alone and in combination with the opioid receptor antagonist naltrexone, attenuates binge-like ethanol drinking.
    Tabbara RI; Li Z; Fletcher PJ; Lê AD
    Addict Biol; 2021 Sep; 26(5):e13040. PubMed ID: 33928736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse inbred strain differences in ethanol drinking to intoxication.
    Rhodes JS; Ford MM; Yu CH; Brown LL; Finn DA; Garland T; Crabbe JC
    Genes Brain Behav; 2007 Feb; 6(1):1-18. PubMed ID: 17233637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone's effects.
    Williams KL; Pakarinen ED; Woods JH
    Psychopharmacology (Berl); 1999 Jun; 144(4):316-22. PubMed ID: 10435403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine enhances the inhibitory effects of naltrexone on ethanol consumption.
    Kuzmin A; Stenback T; Liljequist S
    Eur J Pharmacol; 2008 Apr; 584(2-3):352-6. PubMed ID: 18339371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice.
    Gupta T; Syed YM; Revis AA; Miller SA; Martinez M; Cohn KA; Demeyer MR; Patel KY; Brzezinska WJ; Rhodes JS
    Alcohol Clin Exp Res; 2008 Nov; 32(11):1992-8. PubMed ID: 18782337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of acute effects of melatonin on ethanol drinking in ethanol naïve rats.
    Rather ZA; Chowta MN; Bolumbu G; Rakesh KB
    Indian J Pharmacol; 2015; 47(4):383-7. PubMed ID: 26288469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice.
    Phillips TJ; Wenger CD; Dorow JD
    Alcohol Clin Exp Res; 1997 Jun; 21(4):691-702. PubMed ID: 9194926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking.
    Tanchuck MA; Yoneyama N; Ford MM; Fretwell AM; Finn DA
    Alcohol; 2011 Feb; 45(1):33-44. PubMed ID: 20843635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naltrexone on post-abstinence alcohol drinking in C57BL/6NCRL and DBA/2J mice.
    Tomie A; Azogu I; Yu L
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():240-7. PubMed ID: 23499782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in the effect of bupropion and naltrexone combination on alcohol drinking in mice.
    Zhou Y; Leri F; Low MJ; Kreek MJ
    Pharmacol Biochem Behav; 2019 Jun; 181():28-36. PubMed ID: 30991059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system.
    Valenza M; Blasio A; DiLeo A; Cottone P; Sabino V
    Pharmacol Biochem Behav; 2020 May; 192():172914. PubMed ID: 32205151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic naltrexone treatment and ethanol responsivity in outbred rats.
    Hill KG; Sable HJ; Ferraro Iii FM; Kiefer SW
    Alcohol Clin Exp Res; 2010 Feb; 34(2):272-9. PubMed ID: 19951296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol-reinforced behaviour in the rat: effects of naltrexone.
    Bienkowski P; Kostowski W; Koros E
    Eur J Pharmacol; 1999 Jun; 374(3):321-7. PubMed ID: 10422776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.